Litcius/Paper detail

Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children’s Hospital experience

Erin Crotty, Sarah Leary, J. Russell Geyer, James M. Olson, Nathan E. Millard, Aimee Sato, Ralph P. Ermoian, Bonnie Cole, Christina M. Lockwood, Vera Paulson, Samuel R. Browd, Richard G. Ellenbogen, Jason S. Hauptman, Amy Lee, Jeffrey G. Ojemann, Nicholas A. Vitanza

2020Journal of Neuro-Oncology35 citationsDOI

Topics & Concepts

TemozolomideMedicineBevacizumabIrinotecanRegimenInternal medicineTolerabilityOncologyGliomaDacarbazineSurgeryChemotherapyCancerAdverse effectColorectal cancerCancer researchGlioma Diagnosis and TreatmentBrain Metastases and TreatmentMeningioma and schwannoma management
Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children’s Hospital experience | Litcius